Skip to content

The Effect of Adding Elastic Resistance Training in Routine Physical Exercise on Walking Speed of Elderly People With Sarcopenia in Griya Wreda Jambangan, Surabaya

Elastic Resistance Training for Older Adults With Sarcopenia

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07859969
Enrollment
34
Registered
2026-10-06
Start date
2026-05-01
Completion date
2026-07-18
Last updated
2026-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia in Elderly

Keywords

Sarcopenia, Older Adults, Aged, Elastic Resistance Training, Resistance Training, Gait Speed, Physical Performance, Long-Term Care, Exercise

Brief summary

The goal of this randomized clinical trial is to learn whether adding elastic resistance training (ERT) to routine physical exercise can improve walking speed in older adults aged 60 years or older with sarcopenia living at Griya Wreda Jambangan, Surabaya. Sarcopenia is identified according to the Asian Working Group for Sarcopenia (AWGS) 2019 criteria. The main questions it aims to answer are: * Does adding elastic resistance training to routine physical exercise improve walking speed after 8 weeks? * Is the change in walking speed greater in participants who receive elastic resistance training plus routine physical exercise than in those who receive routine physical exercise alone? Researchers will compare routine physical exercise plus elastic resistance training with routine physical exercise alone to determine whether the addition of elastic resistance training results in greater improvement in walking speed. The study uses a randomized pre- and post-intervention controlled design. Participants will: * Be randomly assigned to either the intervention group or the control group. * Continue the routine physical exercise program provided at Griya Wreda Jambangan. * If assigned to the intervention group, perform elastic resistance training for the upper and lower extremities twice per week for 8 weeks, in addition to routine physical exercise. * Have their walking speed measured before and after the 8-week intervention using a walking test over the middle 6 meters of a 10-meter walkway. * Undergo clinical screening and monitoring to ensure that exercise participation is safe.

Detailed description

This is a randomized controlled clinical trial with a pre- and post-intervention design conducted in older adults with sarcopenia residing at Griya Wreda Jambangan, Surabaya. The study is designed to evaluate whether adding elastic resistance training (ERT) to the participants' routine physical exercise program improves physical performance, particularly walking speed, compared with routine physical exercise alone. Participants are assigned to an intervention group or a control group, and assessments are performed before and after the 8-week intervention period. Participants in both groups continue the routine physical exercise program provided at Griya Wreda Jambangan. This program includes aerobic and flexibility components and is performed at least three times per week for approximately 30 minutes per session. Attendance is recorded to monitor adherence to the routine exercise program. In addition to routine physical exercise, participants in the intervention group receive a structured progressive ERT program using elastic resistance bands. The ERT program is performed twice per week on nonconsecutive days for 8 weeks, with each session lasting approximately 30-45 minutes. Each session includes a warm-up, resistance exercises targeting major upper- and lower-extremity muscle groups, and a cool-down. Upper-extremity exercises include seated chest press, seated row, and seated shoulder press. Lower-extremity exercises include standing hip abduction, standing hip adduction, seated leg press, and standing leg curl. Resistance exercises are performed for three sets of 10-20 repetitions per exercise, with 30-60 seconds of rest between sets. Exercise intensity is prescribed at a moderate perceived level using the OMNI-Resistance Exercise Scale, and resistance is progressively increased according to the participant's ability to complete the prescribed repetitions at the target perceived exertion. When a participant is able to complete 20 repetitions at the specified target exertion, progression is made by using an elastic band with greater resistance. This approach is intended to provide progressive overload while allowing the training load to be individualized according to each participant's capacity. The control group receives the same routine physical exercise program but does not receive the additional ERT intervention during the 8-week study period. Walking performance is assessed in both groups before initiation of the intervention and again after completion of the 8-week period. The protocol specifies that baseline assessment is performed approximately 2 days before the intervention and post-intervention assessment approximately 2 days after the final intervention session. Walking speed is assessed at the participant's usual comfortable walking speed on a 10-meter level walkway. The first 2 meters are used for acceleration and the final 2 meters for deceleration, while the middle 6 meters are timed. Participants complete two trials with a rest interval between trials, and the walking-speed value is calculated from the time required to traverse the timed 6-meter section. The protocol uses the average value from the two trials for analysis. Participants who routinely use a walking aid are permitted to use it during testing. Participant safety is monitored throughout the exercise program. Before ERT sessions, participants undergo clinical assessment to confirm that they are fit to exercise. Blood pressure, heart rate, respiratory rate, body temperature, and oxygen saturation are assessed around the exercise sessions, and symptoms are monitored during training. The protocol includes predefined criteria for withholding or terminating exercise when symptoms or abnormal physiologic responses occur. Exercise is stopped if clinically concerning symptoms develop, if physiologic safety limits are exceeded, if oxygen saturation falls below 90% or decreases substantially from baseline, or if the participant wishes to stop. Adherence to the ERT intervention is documented through session attendance and standardized exercise records, including vital signs, perceived exertion, symptoms, and reasons for exercise termination when applicable. The protocol also specifies withdrawal criteria for participants who discontinue participation, become unable to continue exercise because of illness, or miss the prespecified number of intervention sessions. The statistical analysis plan includes assessment of data distribution using normality testing. Within-group pre- and post-intervention comparisons are analyzed using a paired t-test when assumptions for parametric analysis are met, with the Wilcoxon signed-rank test as the nonparametric alternative. Between-group comparisons are performed using an independent-samples t-test, with the Mann-Whitney U test used when data are not normally distributed. Statistical analyses are performed using SPSS.

Interventions

Elastic resistance training is performed using elastic bands twice per week on nonconsecutive days for 8 weeks. Each session lasts approximately 30-45 minutes and includes warm-up, resistance exercises, and cool-down. Exercises include seated chest press, seated row, seated shoulder press, standing hip abduction, standing hip adduction, seated leg press, and standing leg curl. Each exercise is performed for 3 sets of 10-20 repetitions at moderate intensity (OMNI-RES rating of perceived exertion 4-6), with 30-60 seconds of rest between sets. Resistance is progressively increased when the participant can complete 20 repetitions at the target perceived exertion.

Routine physical exercise is the existing exercise program provided at Griya Wreda Jambangan. The program consists primarily of aerobic and flexibility exercises performed at least three times per week for approximately 30 minutes per session throughout the 8-week study period. The program includes warm-up exercises, stretching and mobility exercises, aerobic movements, and cool-down activities.

Sponsors

Dr. Soetomo General Hospital
Lead SponsorOTHER_GOV
Universitas Airlangga
CollaboratorOTHER
Indonesia Endowment Fund for Education (LPDP), Republic of Indonesia
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Participants, care providers, and investigators were not blinded because of the nature of the exercise intervention. An independent outcomes assessor was blinded to whether participants were assigned to the intervention group or the control group during the pre- and post-intervention outcome assessments.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 60 years or older. * Resident of Griya Wreda Jambangan, Surabaya. * Meets the diagnostic criteria for sarcopenia according to the Asian Working Group for Sarcopenia (AWGS) 2019. * Able to ambulate independently, with or without a walking aid, and has a --Barthel Index score ≥60. * Adequate visual and hearing function. * No cognitive impairment that would interfere with understanding and following instructions, defined as a Montreal Cognitive Assessment-Indonesian Version (MoCA-INA) score ≥26. * Body mass index of 18.5-24.9 kg/m² according to the Asia-Pacific classification. * Willing to participate in the study and provides written informed consent after receiving an explanation of the study.

Exclusion criteria

* Cardiorespiratory disease that may affect physical performance during exercise, including New York Heart Association class III-IV heart failure, chronic obstructive pulmonary disease, acute myocardial infarction, unstable angina, uncontrolled arrhythmia, aneurysm, severe aortic stenosis, acute endocarditis or pericarditis, persistent asthma, or acute or severe respiratory failure. * Blood pressure ≥180/100 mmHg. * Uncontrolled postural hypotension. * Acute thromboembolism, including deep vein thrombosis. * Infectious disease that may affect the participant's general condition or ability to perform the exercise program. * Anatomical abnormality of the upper extremity that prevents handgrip strength assessment. * Fracture within the previous 3 months, or a fracture occurring more than 3 months previously that has not achieved union or interferes with the intervention. * Lower-extremity musculoskeletal disorder with muscle or joint pain rated ≥4 on the Wong-Baker Faces Pain Scale and clinical signs of swelling, redness, or warmth. * Chronic disease that interferes with mobility, including ambulatory impairment due to stroke, uncontrolled diabetes mellitus, or balance disorders due to intracranial or extracranial conditions such as benign paroxysmal positional vertigo or other neurological disorders affecting balance. * Anatomical abnormality of the lower extremity that prevents walking-speed assessment. * Participation in a specific physical exercise program other than the routine physical exercise provided at the nursing home within the previous 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Change in Walking SpeedBaseline and 8 weeks after the intervention periodWalking speed is measured in meters per second using a stopwatch on a 10-meter level walkway. The first 2 meters are used for acceleration and the final 2 meters for deceleration. The time required to walk the middle 6 meters at the participant's usual comfortable walking speed is recorded, and walking speed is calculated in meters per second.

Countries

Indonesia

Contacts

STUDY_CHAIRAbdul Jabbar Al Hayyan, Physiatrist, MD

Dr. Soetomo General Hospital

STUDY_CHAIRLydia Arfianti, Physiatrist, MD

Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

PRINCIPAL_INVESTIGATORTrinita Diyah Permatasari

Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Oct 14, 2026